SEC Comment Letter 0000000000-24-012418 to Affimed N.V. (AFMD) (CIK 0001608390)
Affimed N.V. (AFMD) (CIK 0001608390)
Date: Nov. 7, 2024 · CIK: 0001608390 · Accession: 0000000000-24-012418
AI Filing Summary & Sentiment
File numbers found in text: 333-282978
Letter
November 7, 2024 Shawn Leland Chief Executive Officer Affimed N.V. Gottlieb-Daimler-Straße 2, 68165 Mannheim Germany Re:Affimed N.V. Registration Statement on Form F-3 Filed November 4, 2024 File No. 333-282978 Dear Shawn Leland: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Sophia Hudson, P.C.
Show Raw Text
November 7, 2024
Shawn Leland
Chief Executive Officer
Affimed N.V.
Gottlieb-Daimler-Straße 2,
68165 Mannheim
Germany
Re:Affimed N.V.
Registration Statement on Form F-3
Filed November 4, 2024
File No. 333-282978
Dear Shawn Leland:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Sophia Hudson, P.C.